nodes	percent_of_prediction	percent_of_DWPC	metapath
Estramustine—Testosterone—Hydrocortisone—psoriasis	0.148	0.543	CrCrCtD
Estramustine—Testosterone—Prednisolone—psoriasis	0.124	0.457	CrCrCtD
Estramustine—CYP3A4—Calcitriol—psoriasis	0.0435	0.103	CbGbCtD
Estramustine—CYP3A4—Methoxsalen—psoriasis	0.0339	0.0804	CbGbCtD
Estramustine—ABCB1—Mycophenolate mofetil—psoriasis	0.0325	0.0771	CbGbCtD
Estramustine—ABCB1—Betamethasone—psoriasis	0.0278	0.0661	CbGbCtD
Estramustine—ABCB1—Prednisolone—psoriasis	0.0275	0.0653	CbGbCtD
Estramustine—ABCB1—Hydrocortisone—psoriasis	0.026	0.0619	CbGbCtD
Estramustine—ABCB1—Prednisone—psoriasis	0.0259	0.0616	CbGbCtD
Estramustine—ABCB1—Cyclosporine—psoriasis	0.0246	0.0584	CbGbCtD
Estramustine—CYP3A4—Cholecalciferol—psoriasis	0.0224	0.0533	CbGbCtD
Estramustine—CYP3A4—Mycophenolate mofetil—psoriasis	0.0194	0.0462	CbGbCtD
Estramustine—CYP3A4—Triamcinolone—psoriasis	0.0194	0.0462	CbGbCtD
Estramustine—CYP3A4—Betamethasone—psoriasis	0.0167	0.0396	CbGbCtD
Estramustine—CYP3A4—Prednisolone—psoriasis	0.0165	0.0391	CbGbCtD
Estramustine—ABCB1—Dexamethasone—psoriasis	0.0162	0.0385	CbGbCtD
Estramustine—CYP3A4—Hydrocortisone—psoriasis	0.0156	0.0371	CbGbCtD
Estramustine—CYP3A4—Prednisone—psoriasis	0.0155	0.0369	CbGbCtD
Estramustine—CYP3A4—Cyclosporine—psoriasis	0.0147	0.035	CbGbCtD
Estramustine—ABCB1—Methotrexate—psoriasis	0.013	0.0309	CbGbCtD
Estramustine—CYP3A4—Dexamethasone—psoriasis	0.0097	0.0231	CbGbCtD
Estramustine—MAP2—Melatonin metabolism and effects—APOE—psoriasis	0.00216	0.0553	CbGpPWpGaD
Estramustine—MAP2—SIDS Susceptibility Pathways—RUNX3—psoriasis	0.00138	0.0354	CbGpPWpGaD
Estramustine—MAP2—MAPK Cascade—JUN—psoriasis	0.00133	0.0342	CbGpPWpGaD
Estramustine—MAP2—Melatonin metabolism and effects—NFKB1—psoriasis	0.00128	0.0329	CbGpPWpGaD
Estramustine—MAP2—SIDS Susceptibility Pathways—IL13—psoriasis	0.00109	0.028	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—IL22—psoriasis	0.00103	0.0264	CbGpPWpGaD
Estramustine—ESR2—Ovarian Infertility Genes—VDR—psoriasis	0.000962	0.0246	CbGpPWpGaD
Estramustine—ESR1—ATF-2 transcription factor network—IL23A—psoriasis	0.000908	0.0233	CbGpPWpGaD
Estramustine—ESR2—Nuclear Receptors—VDR—psoriasis	0.000838	0.0215	CbGpPWpGaD
Estramustine—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.000789	0.0202	CbGpPWpGaD
Estramustine—MAP2—SIDS Susceptibility Pathways—IL10—psoriasis	0.000683	0.0175	CbGpPWpGaD
Estramustine—ESR2—Nuclear Receptor transcription pathway—VDR—psoriasis	0.000662	0.017	CbGpPWpGaD
Estramustine—ESR1—FOXM1 transcription factor network—TGFA—psoriasis	0.000653	0.0167	CbGpPWpGaD
Estramustine—MAP2—LKB1 signaling events—TP53—psoriasis	0.000643	0.0165	CbGpPWpGaD
Estramustine—ESR2—Nuclear Receptors—PPARG—psoriasis	0.000584	0.015	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—RUNX3—psoriasis	0.000533	0.0137	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	0.000502	0.0129	CbGpPWpGaD
Estramustine—ESR1—Estrogen Receptor Pathway—JUN—psoriasis	0.000493	0.0126	CbGpPWpGaD
Estramustine—ESR2—Validated nuclear estrogen receptor alpha network—PCNA—psoriasis	0.00049	0.0126	CbGpPWpGaD
Estramustine—Mood swings—Prednisolone—psoriasis	0.000486	0.00181	CcSEcCtD
Estramustine—Cardiac arrest—Hydrocortisone—psoriasis	0.000476	0.00178	CcSEcCtD
Estramustine—Mood swings—Hydrocortisone—psoriasis	0.000474	0.00177	CcSEcCtD
Estramustine—Eye pain—Dexamethasone—psoriasis	0.000474	0.00177	CcSEcCtD
Estramustine—Eye pain—Betamethasone—psoriasis	0.000474	0.00177	CcSEcCtD
Estramustine—Cardiac failure congestive—Dexamethasone—psoriasis	0.000472	0.00176	CcSEcCtD
Estramustine—Cardiac failure congestive—Betamethasone—psoriasis	0.000472	0.00176	CcSEcCtD
Estramustine—Insomnia—Acitretin—psoriasis	0.000471	0.00176	CcSEcCtD
Estramustine—Dry skin—Prednisolone—psoriasis	0.00047	0.00175	CcSEcCtD
Estramustine—Abdominal discomfort—Cyclosporine—psoriasis	0.000467	0.00174	CcSEcCtD
Estramustine—Pruritus—Methoxsalen—psoriasis	0.000465	0.00173	CcSEcCtD
Estramustine—Affect lability—Triamcinolone—psoriasis	0.000464	0.00173	CcSEcCtD
Estramustine—ESR2—Nuclear Receptor transcription pathway—PPARG—psoriasis	0.000462	0.0118	CbGpPWpGaD
Estramustine—Dry skin—Hydrocortisone—psoriasis	0.000459	0.00171	CcSEcCtD
Estramustine—ESR1—Regulation of nuclear SMAD2/3 signaling—RUNX3—psoriasis	0.000454	0.0116	CbGpPWpGaD
Estramustine—Decreased appetite—Acitretin—psoriasis	0.000453	0.00169	CcSEcCtD
Estramustine—Pancytopenia—Mycophenolate mofetil—psoriasis	0.000451	0.00168	CcSEcCtD
Estramustine—Tinnitus—Mycophenolic acid—psoriasis	0.000449	0.00168	CcSEcCtD
Estramustine—Cardiac arrest—Triamcinolone—psoriasis	0.000448	0.00167	CcSEcCtD
Estramustine—Leukopenia—Hydroxyurea—psoriasis	0.000448	0.00167	CcSEcCtD
Estramustine—Mood swings—Triamcinolone—psoriasis	0.000447	0.00167	CcSEcCtD
Estramustine—Erectile dysfunction—Mycophenolate mofetil—psoriasis	0.000438	0.00163	CcSEcCtD
Estramustine—Lethargy—Betamethasone—psoriasis	0.000437	0.00163	CcSEcCtD
Estramustine—Lethargy—Dexamethasone—psoriasis	0.000437	0.00163	CcSEcCtD
Estramustine—Depression—Cyclosporine—psoriasis	0.000433	0.00162	CcSEcCtD
Estramustine—Thrombophlebitis—Prednisone—psoriasis	0.00043	0.00161	CcSEcCtD
Estramustine—Acute coronary syndrome—Cyclosporine—psoriasis	0.000428	0.0016	CcSEcCtD
Estramustine—ESR1—Estrogen Receptor Pathway—STAT3—psoriasis	0.000426	0.0109	CbGpPWpGaD
Estramustine—Alopecia—Mycophenolic acid—psoriasis	0.000426	0.00159	CcSEcCtD
Estramustine—Myocardial infarction—Cyclosporine—psoriasis	0.000426	0.00159	CcSEcCtD
Estramustine—ABCB1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000426	0.0109	CbGpPWpGaD
Estramustine—ESR1—Nuclear Receptors—VDR—psoriasis	0.000423	0.0108	CbGpPWpGaD
Estramustine—Depression—Mycophenolate mofetil—psoriasis	0.000422	0.00158	CcSEcCtD
Estramustine—Affect lability—Dexamethasone—psoriasis	0.000421	0.00157	CcSEcCtD
Estramustine—Affect lability—Betamethasone—psoriasis	0.000421	0.00157	CcSEcCtD
Estramustine—ESR2—SIDS Susceptibility Pathways—IL13—psoriasis	0.000421	0.0108	CbGpPWpGaD
Estramustine—Acute coronary syndrome—Mycophenolate mofetil—psoriasis	0.000418	0.00156	CcSEcCtD
Estramustine—ESR1—Leptin signaling pathway—REL—psoriasis	0.000417	0.0107	CbGpPWpGaD
Estramustine—Myocardial infarction—Mycophenolate mofetil—psoriasis	0.000415	0.00155	CcSEcCtD
Estramustine—Pruritus—Calcitriol—psoriasis	0.000414	0.00155	CcSEcCtD
Estramustine—Rash—Methoxsalen—psoriasis	0.000414	0.00155	CcSEcCtD
Estramustine—Dermatitis—Methoxsalen—psoriasis	0.000414	0.00154	CcSEcCtD
Estramustine—Flatulence—Mycophenolic acid—psoriasis	0.000413	0.00154	CcSEcCtD
Estramustine—Headache—Methoxsalen—psoriasis	0.000411	0.00154	CcSEcCtD
Estramustine—Cardiac failure congestive—Prednisone—psoriasis	0.000411	0.00153	CcSEcCtD
Estramustine—Skin exfoliation—Methotrexate—psoriasis	0.00041	0.00153	CcSEcCtD
Estramustine—Oedema—Hydroxyurea—psoriasis	0.000409	0.00153	CcSEcCtD
Estramustine—Cardiac arrest—Dexamethasone—psoriasis	0.000407	0.00152	CcSEcCtD
Estramustine—Cardiac arrest—Betamethasone—psoriasis	0.000407	0.00152	CcSEcCtD
Estramustine—Mood swings—Dexamethasone—psoriasis	0.000405	0.00151	CcSEcCtD
Estramustine—Mood swings—Betamethasone—psoriasis	0.000405	0.00151	CcSEcCtD
Estramustine—Muscle spasms—Mycophenolic acid—psoriasis	0.000403	0.00151	CcSEcCtD
Estramustine—Diarrhoea—Calcitriol—psoriasis	0.0004	0.00149	CcSEcCtD
Estramustine—Thrombocytopenia—Hydroxyurea—psoriasis	0.0004	0.00149	CcSEcCtD
Estramustine—Dry skin—Dexamethasone—psoriasis	0.000392	0.00146	CcSEcCtD
Estramustine—Dry skin—Betamethasone—psoriasis	0.000392	0.00146	CcSEcCtD
Estramustine—Nausea—Methoxsalen—psoriasis	0.00039	0.00146	CcSEcCtD
Estramustine—Anorexia—Hydroxyurea—psoriasis	0.00039	0.00145	CcSEcCtD
Estramustine—Acute coronary syndrome—Prednisolone—psoriasis	0.00039	0.00145	CcSEcCtD
Estramustine—Myocardial infarction—Prednisolone—psoriasis	0.000387	0.00145	CcSEcCtD
Estramustine—Gynaecomastia—Methotrexate—psoriasis	0.000384	0.00143	CcSEcCtD
Estramustine—Acute coronary syndrome—Hydrocortisone—psoriasis	0.00038	0.00142	CcSEcCtD
Estramustine—Lethargy—Prednisone—psoriasis	0.00038	0.00142	CcSEcCtD
Estramustine—Myocardial infarction—Hydrocortisone—psoriasis	0.000378	0.00141	CcSEcCtD
Estramustine—Leukopenia—Mycophenolic acid—psoriasis	0.000376	0.0014	CcSEcCtD
Estramustine—MAP2—SIDS Susceptibility Pathways—CXCL8—psoriasis	0.000374	0.00957	CbGpPWpGaD
Estramustine—Gastrointestinal haemorrhage—Prednisone—psoriasis	0.000373	0.00139	CcSEcCtD
Estramustine—Vomiting—Calcitriol—psoriasis	0.000372	0.00139	CcSEcCtD
Estramustine—Rash—Calcitriol—psoriasis	0.000369	0.00138	CcSEcCtD
Estramustine—Dermatitis—Calcitriol—psoriasis	0.000369	0.00138	CcSEcCtD
Estramustine—Pruritus—Acitretin—psoriasis	0.000368	0.00138	CcSEcCtD
Estramustine—Pruritus—Fluocinolone Acetonide—psoriasis	0.000367	0.00137	CcSEcCtD
Estramustine—Affect lability—Prednisone—psoriasis	0.000367	0.00137	CcSEcCtD
Estramustine—Headache—Calcitriol—psoriasis	0.000367	0.00137	CcSEcCtD
Estramustine—Dyspnoea—Hydroxyurea—psoriasis	0.000364	0.00136	CcSEcCtD
Estramustine—ESR1—Integrated Breast Cancer Pathway—ZMIZ1—psoriasis	0.000364	0.00933	CbGpPWpGaD
Estramustine—Tinnitus—Cyclosporine—psoriasis	0.000363	0.00136	CcSEcCtD
Estramustine—Flushing—Cyclosporine—psoriasis	0.000362	0.00135	CcSEcCtD
Estramustine—Thrombophlebitis—Methotrexate—psoriasis	0.00036	0.00134	CcSEcCtD
Estramustine—Acute coronary syndrome—Triamcinolone—psoriasis	0.000358	0.00134	CcSEcCtD
Estramustine—Chest pain—Mycophenolic acid—psoriasis	0.000357	0.00133	CcSEcCtD
Estramustine—Diarrhoea—Acitretin—psoriasis	0.000356	0.00133	CcSEcCtD
Estramustine—Myocardial infarction—Triamcinolone—psoriasis	0.000356	0.00133	CcSEcCtD
Estramustine—Anxiety—Mycophenolic acid—psoriasis	0.000356	0.00133	CcSEcCtD
Estramustine—Decreased appetite—Hydroxyurea—psoriasis	0.000355	0.00133	CcSEcCtD
Estramustine—Diarrhoea—Fluocinolone Acetonide—psoriasis	0.000355	0.00133	CcSEcCtD
Estramustine—Tinnitus—Mycophenolate mofetil—psoriasis	0.000355	0.00132	CcSEcCtD
Estramustine—Cardiac arrest—Prednisone—psoriasis	0.000354	0.00132	CcSEcCtD
Estramustine—Mood swings—Prednisone—psoriasis	0.000353	0.00132	CcSEcCtD
Estramustine—Nausea—Calcitriol—psoriasis	0.000348	0.0013	CcSEcCtD
Estramustine—MAP2—SIDS Susceptibility Pathways—JUN—psoriasis	0.000347	0.0089	CbGpPWpGaD
Estramustine—Alopecia—Cyclosporine—psoriasis	0.000345	0.00129	CcSEcCtD
Estramustine—Oedema—Mycophenolic acid—psoriasis	0.000342	0.00128	CcSEcCtD
Estramustine—Dry skin—Prednisone—psoriasis	0.000342	0.00127	CcSEcCtD
Estramustine—ESR1—Signaling mediated by p38-alpha and p38-beta—NOS2—psoriasis	0.000337	0.00863	CbGpPWpGaD
Estramustine—Alopecia—Mycophenolate mofetil—psoriasis	0.000336	0.00125	CcSEcCtD
Estramustine—Thrombocytopenia—Mycophenolic acid—psoriasis	0.000335	0.00125	CcSEcCtD
Estramustine—Flatulence—Cyclosporine—psoriasis	0.000334	0.00125	CcSEcCtD
Estramustine—MAP2—SIDS Susceptibility Pathways—NFKB1—psoriasis	0.000334	0.00857	CbGpPWpGaD
Estramustine—ESR1—Nuclear Receptor transcription pathway—VDR—psoriasis	0.000334	0.00856	CbGpPWpGaD
Estramustine—Vomiting—Acitretin—psoriasis	0.000331	0.00124	CcSEcCtD
Estramustine—Vomiting—Fluocinolone Acetonide—psoriasis	0.00033	0.00123	CcSEcCtD
Estramustine—Rash—Acitretin—psoriasis	0.000328	0.00123	CcSEcCtD
Estramustine—Dermatitis—Acitretin—psoriasis	0.000328	0.00122	CcSEcCtD
Estramustine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000328	0.0084	CbGpPWpGaD
Estramustine—Rash—Fluocinolone Acetonide—psoriasis	0.000327	0.00122	CcSEcCtD
Estramustine—Dermatitis—Fluocinolone Acetonide—psoriasis	0.000327	0.00122	CcSEcCtD
Estramustine—Anorexia—Mycophenolic acid—psoriasis	0.000326	0.00122	CcSEcCtD
Estramustine—Muscle spasms—Cyclosporine—psoriasis	0.000326	0.00122	CcSEcCtD
Estramustine—Flatulence—Mycophenolate mofetil—psoriasis	0.000326	0.00122	CcSEcCtD
Estramustine—Headache—Acitretin—psoriasis	0.000326	0.00122	CcSEcCtD
Estramustine—Headache—Fluocinolone Acetonide—psoriasis	0.000325	0.00121	CcSEcCtD
Estramustine—Acute coronary syndrome—Dexamethasone—psoriasis	0.000325	0.00121	CcSEcCtD
Estramustine—Acute coronary syndrome—Betamethasone—psoriasis	0.000325	0.00121	CcSEcCtD
Estramustine—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000324	0.00829	CbGpPWpGaD
Estramustine—Myocardial infarction—Dexamethasone—psoriasis	0.000323	0.00121	CcSEcCtD
Estramustine—Myocardial infarction—Betamethasone—psoriasis	0.000323	0.00121	CcSEcCtD
Estramustine—Muscle spasms—Mycophenolate mofetil—psoriasis	0.000318	0.00119	CcSEcCtD
Estramustine—Cerebrovascular accident—Methotrexate—psoriasis	0.000318	0.00119	CcSEcCtD
Estramustine—Lethargy—Methotrexate—psoriasis	0.000318	0.00119	CcSEcCtD
Estramustine—ESR1—Estrogen signaling pathway—JUN—psoriasis	0.000312	0.008	CbGpPWpGaD
Estramustine—Insomnia—Mycophenolic acid—psoriasis	0.00031	0.00116	CcSEcCtD
Estramustine—Nausea—Acitretin—psoriasis	0.000309	0.00115	CcSEcCtD
Estramustine—Nausea—Fluocinolone Acetonide—psoriasis	0.000308	0.00115	CcSEcCtD
Estramustine—Dyspnoea—Mycophenolic acid—psoriasis	0.000305	0.00114	CcSEcCtD
Estramustine—Leukopenia—Cyclosporine—psoriasis	0.000304	0.00113	CcSEcCtD
Estramustine—MAP2—SIDS Susceptibility Pathways—VEGFA—psoriasis	0.000303	0.00777	CbGpPWpGaD
Estramustine—ESR1—Estrogen signaling pathway—NFKB1—psoriasis	0.000301	0.0077	CbGpPWpGaD
Estramustine—Decreased appetite—Mycophenolic acid—psoriasis	0.000298	0.00111	CcSEcCtD
Estramustine—Erectile dysfunction—Prednisone—psoriasis	0.000297	0.00111	CcSEcCtD
Estramustine—Leukopenia—Mycophenolate mofetil—psoriasis	0.000296	0.00111	CcSEcCtD
Estramustine—Mood swings—Methotrexate—psoriasis	0.000295	0.0011	CcSEcCtD
Estramustine—ESR1—Nuclear Receptors—PPARG—psoriasis	0.000295	0.00755	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—TARS—psoriasis	0.000293	0.00751	CbGpPWpGaD
Estramustine—Chest pain—Cyclosporine—psoriasis	0.000289	0.00108	CcSEcCtD
Estramustine—Anxiety—Cyclosporine—psoriasis	0.000288	0.00107	CcSEcCtD
Estramustine—Liver function test abnormal—Methotrexate—psoriasis	0.000288	0.00107	CcSEcCtD
Estramustine—Depression—Prednisone—psoriasis	0.000286	0.00107	CcSEcCtD
Estramustine—Acute coronary syndrome—Prednisone—psoriasis	0.000283	0.00106	CcSEcCtD
Estramustine—Chest pain—Mycophenolate mofetil—psoriasis	0.000282	0.00105	CcSEcCtD
Estramustine—Myocardial infarction—Prednisone—psoriasis	0.000281	0.00105	CcSEcCtD
Estramustine—Anxiety—Mycophenolate mofetil—psoriasis	0.000281	0.00105	CcSEcCtD
Estramustine—Diarrhoea—Hydroxyurea—psoriasis	0.00028	0.00104	CcSEcCtD
Estramustine—Oedema—Cyclosporine—psoriasis	0.000277	0.00103	CcSEcCtD
Estramustine—ESR2—Validated nuclear estrogen receptor alpha network—JUN—psoriasis	0.000273	0.007	CbGpPWpGaD
Estramustine—Thrombocytopenia—Cyclosporine—psoriasis	0.000271	0.00101	CcSEcCtD
Estramustine—Oedema—Mycophenolate mofetil—psoriasis	0.00027	0.00101	CcSEcCtD
Estramustine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000266	0.00681	CbGpPWpGaD
Estramustine—Thrombocytopenia—Mycophenolate mofetil—psoriasis	0.000265	0.000987	CcSEcCtD
Estramustine—Anorexia—Cyclosporine—psoriasis	0.000264	0.000985	CcSEcCtD
Estramustine—ESR2—SIDS Susceptibility Pathways—IL10—psoriasis	0.000263	0.00675	CbGpPWpGaD
Estramustine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000262	0.00672	CbGpPWpGaD
Estramustine—Alopecia—Dexamethasone—psoriasis	0.000262	0.000976	CcSEcCtD
Estramustine—Alopecia—Betamethasone—psoriasis	0.000262	0.000976	CcSEcCtD
Estramustine—MAP2—SIDS Susceptibility Pathways—TNF—psoriasis	0.00026	0.00666	CbGpPWpGaD
Estramustine—Vomiting—Hydroxyurea—psoriasis	0.00026	0.00097	CcSEcCtD
Estramustine—Abdominal discomfort—Methotrexate—psoriasis	0.000258	0.000963	CcSEcCtD
Estramustine—Rash—Hydroxyurea—psoriasis	0.000258	0.000962	CcSEcCtD
Estramustine—Anorexia—Mycophenolate mofetil—psoriasis	0.000258	0.000961	CcSEcCtD
Estramustine—Dermatitis—Hydroxyurea—psoriasis	0.000258	0.000961	CcSEcCtD
Estramustine—Headache—Hydroxyurea—psoriasis	0.000256	0.000956	CcSEcCtD
Estramustine—Anxiety—Hydrocortisone—psoriasis	0.000256	0.000955	CcSEcCtD
Estramustine—Pancytopenia—Methotrexate—psoriasis	0.000256	0.000954	CcSEcCtD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	0.000253	0.00648	CbGpPWpGaD
Estramustine—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	0.000252	0.00647	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—IL10—psoriasis	0.000252	0.00646	CbGpPWpGaD
Estramustine—Oedema—Prednisolone—psoriasis	0.000252	0.000941	CcSEcCtD
Estramustine—Insomnia—Cyclosporine—psoriasis	0.000251	0.000935	CcSEcCtD
Estramustine—Erectile dysfunction—Methotrexate—psoriasis	0.000248	0.000925	CcSEcCtD
Estramustine—ESR1—Validated nuclear estrogen receptor alpha network—PCNA—psoriasis	0.000247	0.00634	CbGpPWpGaD
Estramustine—Dyspnoea—Cyclosporine—psoriasis	0.000247	0.000922	CcSEcCtD
Estramustine—Oedema—Hydrocortisone—psoriasis	0.000246	0.000919	CcSEcCtD
Estramustine—ESR1—AP-1 transcription factor network—IL4—psoriasis	0.000245	0.00629	CbGpPWpGaD
Estramustine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000244	0.00626	CbGpPWpGaD
Estramustine—Insomnia—Mycophenolate mofetil—psoriasis	0.000244	0.000912	CcSEcCtD
Estramustine—Nausea—Hydroxyurea—psoriasis	0.000243	0.000906	CcSEcCtD
Estramustine—Pruritus—Mycophenolic acid—psoriasis	0.000242	0.000904	CcSEcCtD
Estramustine—Dyspnoea—Mycophenolate mofetil—psoriasis	0.000241	0.000899	CcSEcCtD
Estramustine—Decreased appetite—Cyclosporine—psoriasis	0.000241	0.000899	CcSEcCtD
Estramustine—Depression—Methotrexate—psoriasis	0.000239	0.000893	CcSEcCtD
Estramustine—Flushing—Prednisone—psoriasis	0.000239	0.000893	CcSEcCtD
Estramustine—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000235	0.000877	CcSEcCtD
Estramustine—Anorexia—Hydrocortisone—psoriasis	0.000235	0.000876	CcSEcCtD
Estramustine—Diarrhoea—Mycophenolic acid—psoriasis	0.000234	0.000874	CcSEcCtD
Estramustine—ESR1—Nuclear Receptor transcription pathway—PPARG—psoriasis	0.000233	0.00597	CbGpPWpGaD
Estramustine—Oedema—Triamcinolone—psoriasis	0.000232	0.000865	CcSEcCtD
Estramustine—ESR1—Regulation of nuclear SMAD2/3 signaling—VDR—psoriasis	0.000231	0.00591	CbGpPWpGaD
Estramustine—Insomnia—Prednisolone—psoriasis	0.000228	0.000851	CcSEcCtD
Estramustine—Alopecia—Prednisone—psoriasis	0.000228	0.00085	CcSEcCtD
Estramustine—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—psoriasis	0.000224	0.00575	CbGpPWpGaD
Estramustine—ESR1—Signaling mediated by p38-alpha and p38-beta—JUN—psoriasis	0.000223	0.00572	CbGpPWpGaD
Estramustine—Insomnia—Hydrocortisone—psoriasis	0.000223	0.000831	CcSEcCtD
Estramustine—ESR1—AP-1 transcription factor network—HLA-A—psoriasis	0.000222	0.0057	CbGpPWpGaD
Estramustine—ESR1—ATF-2 transcription factor network—NOS2—psoriasis	0.000222	0.00568	CbGpPWpGaD
Estramustine—Anxiety—Dexamethasone—psoriasis	0.000219	0.000816	CcSEcCtD
Estramustine—Anxiety—Betamethasone—psoriasis	0.000219	0.000816	CcSEcCtD
Estramustine—Vomiting—Mycophenolic acid—psoriasis	0.000218	0.000813	CcSEcCtD
Estramustine—Rash—Mycophenolic acid—psoriasis	0.000216	0.000806	CcSEcCtD
Estramustine—Dermatitis—Mycophenolic acid—psoriasis	0.000216	0.000805	CcSEcCtD
Estramustine—Headache—Mycophenolic acid—psoriasis	0.000214	0.000801	CcSEcCtD
Estramustine—Decreased appetite—Hydrocortisone—psoriasis	0.000214	0.000799	CcSEcCtD
Estramustine—Oedema—Dexamethasone—psoriasis	0.00021	0.000785	CcSEcCtD
Estramustine—Oedema—Betamethasone—psoriasis	0.00021	0.000785	CcSEcCtD
Estramustine—MAP2—SIDS Susceptibility Pathways—IL6—psoriasis	0.00021	0.00538	CbGpPWpGaD
Estramustine—Insomnia—Triamcinolone—psoriasis	0.00021	0.000782	CcSEcCtD
Estramustine—Dyspnoea—Triamcinolone—psoriasis	0.000207	0.000771	CcSEcCtD
Estramustine—Thrombocytopenia—Betamethasone—psoriasis	0.000206	0.000769	CcSEcCtD
Estramustine—Thrombocytopenia—Dexamethasone—psoriasis	0.000206	0.000769	CcSEcCtD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	0.000204	0.00524	CbGpPWpGaD
Estramustine—Nausea—Mycophenolic acid—psoriasis	0.000203	0.000759	CcSEcCtD
Estramustine—Tinnitus—Methotrexate—psoriasis	0.000201	0.00075	CcSEcCtD
Estramustine—Anorexia—Dexamethasone—psoriasis	0.0002	0.000748	CcSEcCtD
Estramustine—Anorexia—Betamethasone—psoriasis	0.0002	0.000748	CcSEcCtD
Estramustine—ESR1—Leptin signaling pathway—LEP—psoriasis	0.000196	0.00503	CbGpPWpGaD
Estramustine—Pruritus—Cyclosporine—psoriasis	0.000196	0.000731	CcSEcCtD
Estramustine—ABCB1—Allograft Rejection—HLA-C—psoriasis	0.000195	0.00499	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—IL13—psoriasis	0.000194	0.00496	CbGpPWpGaD
Estramustine—ESR2—Generic Transcription Pathway—CARM1—psoriasis	0.000192	0.00491	CbGpPWpGaD
Estramustine—Pruritus—Mycophenolate mofetil—psoriasis	0.000191	0.000714	CcSEcCtD
Estramustine—Anxiety—Prednisone—psoriasis	0.00019	0.000711	CcSEcCtD
Estramustine—Alopecia—Methotrexate—psoriasis	0.00019	0.000711	CcSEcCtD
Estramustine—Insomnia—Betamethasone—psoriasis	0.00019	0.00071	CcSEcCtD
Estramustine—Insomnia—Dexamethasone—psoriasis	0.00019	0.00071	CcSEcCtD
Estramustine—Diarrhoea—Cyclosporine—psoriasis	0.00019	0.000707	CcSEcCtD
Estramustine—ESR1—FOXA1 transcription factor network—JUN—psoriasis	0.000186	0.00476	CbGpPWpGaD
Estramustine—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000185	0.00069	CcSEcCtD
Estramustine—Oedema—Prednisone—psoriasis	0.000183	0.000684	CcSEcCtD
Estramustine—Decreased appetite—Betamethasone—psoriasis	0.000183	0.000682	CcSEcCtD
Estramustine—Decreased appetite—Dexamethasone—psoriasis	0.000183	0.000682	CcSEcCtD
Estramustine—ABCB1—Allograft Rejection—IL17A—psoriasis	0.000178	0.00457	CbGpPWpGaD
Estramustine—Vomiting—Cyclosporine—psoriasis	0.000176	0.000657	CcSEcCtD
Estramustine—Rash—Cyclosporine—psoriasis	0.000175	0.000652	CcSEcCtD
Estramustine—Anorexia—Prednisone—psoriasis	0.000175	0.000652	CcSEcCtD
Estramustine—Dermatitis—Cyclosporine—psoriasis	0.000174	0.000651	CcSEcCtD
Estramustine—Pruritus—Hydrocortisone—psoriasis	0.000174	0.00065	CcSEcCtD
Estramustine—Headache—Cyclosporine—psoriasis	0.000174	0.000648	CcSEcCtD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	0.000173	0.00442	CbGpPWpGaD
Estramustine—Vomiting—Mycophenolate mofetil—psoriasis	0.000172	0.000641	CcSEcCtD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	0.000172	0.0044	CbGpPWpGaD
Estramustine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.00017	0.00437	CbGpPWpGaD
Estramustine—Rash—Mycophenolate mofetil—psoriasis	0.00017	0.000636	CcSEcCtD
Estramustine—Dermatitis—Mycophenolate mofetil—psoriasis	0.00017	0.000635	CcSEcCtD
Estramustine—ESR1—ATF-2 transcription factor network—IFNG—psoriasis	0.00017	0.00436	CbGpPWpGaD
Estramustine—Headache—Mycophenolate mofetil—psoriasis	0.000169	0.000632	CcSEcCtD
Estramustine—Diarrhoea—Hydrocortisone—psoriasis	0.000168	0.000629	CcSEcCtD
Estramustine—Leukopenia—Methotrexate—psoriasis	0.000168	0.000627	CcSEcCtD
Estramustine—Insomnia—Prednisone—psoriasis	0.000166	0.000618	CcSEcCtD
Estramustine—ABCB1—Allograft Rejection—IL12B—psoriasis	0.000166	0.00424	CbGpPWpGaD
Estramustine—Nausea—Cyclosporine—psoriasis	0.000165	0.000614	CcSEcCtD
Estramustine—Pruritus—Triamcinolone—psoriasis	0.000164	0.000612	CcSEcCtD
Estramustine—ABCB1—Allograft Rejection—HLA-E—psoriasis	0.000162	0.00414	CbGpPWpGaD
Estramustine—Nausea—Mycophenolate mofetil—psoriasis	0.00016	0.000599	CcSEcCtD
Estramustine—Chest pain—Methotrexate—psoriasis	0.00016	0.000596	CcSEcCtD
Estramustine—Decreased appetite—Prednisone—psoriasis	0.000159	0.000594	CcSEcCtD
Estramustine—Rash—Prednisolone—psoriasis	0.000159	0.000593	CcSEcCtD
Estramustine—Dermatitis—Prednisolone—psoriasis	0.000159	0.000593	CcSEcCtD
Estramustine—ESR1—ATF-2 transcription factor network—CXCL8—psoriasis	0.000158	0.00405	CbGpPWpGaD
Estramustine—Headache—Prednisolone—psoriasis	0.000158	0.000589	CcSEcCtD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	0.000157	0.00402	CbGpPWpGaD
Estramustine—Vomiting—Hydrocortisone—psoriasis	0.000157	0.000584	CcSEcCtD
Estramustine—Rash—Hydrocortisone—psoriasis	0.000155	0.000579	CcSEcCtD
Estramustine—Dermatitis—Hydrocortisone—psoriasis	0.000155	0.000579	CcSEcCtD
Estramustine—Headache—Hydrocortisone—psoriasis	0.000154	0.000576	CcSEcCtD
Estramustine—ESR1—Regulation of Telomerase—IFNG—psoriasis	0.000152	0.00389	CbGpPWpGaD
Estramustine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000151	0.00386	CbGpPWpGaD
Estramustine—Thrombocytopenia—Methotrexate—psoriasis	0.00015	0.000559	CcSEcCtD
Estramustine—Nausea—Prednisolone—psoriasis	0.00015	0.000559	CcSEcCtD
Estramustine—Pruritus—Dexamethasone—psoriasis	0.000149	0.000555	CcSEcCtD
Estramustine—Pruritus—Betamethasone—psoriasis	0.000149	0.000555	CcSEcCtD
Estramustine—ESR1—AP-1 transcription factor network—IFNG—psoriasis	0.000148	0.0038	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—TARS—psoriasis	0.000148	0.00379	CbGpPWpGaD
Estramustine—Vomiting—Triamcinolone—psoriasis	0.000147	0.00055	CcSEcCtD
Estramustine—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—psoriasis	0.000147	0.00378	CbGpPWpGaD
Estramustine—ESR1—ATF-2 transcription factor network—JUN—psoriasis	0.000147	0.00377	CbGpPWpGaD
Estramustine—Nausea—Hydrocortisone—psoriasis	0.000146	0.000546	CcSEcCtD
Estramustine—Rash—Triamcinolone—psoriasis	0.000146	0.000545	CcSEcCtD
Estramustine—Dermatitis—Triamcinolone—psoriasis	0.000146	0.000545	CcSEcCtD
Estramustine—Anorexia—Methotrexate—psoriasis	0.000146	0.000545	CcSEcCtD
Estramustine—Headache—Triamcinolone—psoriasis	0.000145	0.000542	CcSEcCtD
Estramustine—ESR2—SIDS Susceptibility Pathways—CXCL8—psoriasis	0.000144	0.00369	CbGpPWpGaD
Estramustine—Diarrhoea—Dexamethasone—psoriasis	0.000144	0.000537	CcSEcCtD
Estramustine—Diarrhoea—Betamethasone—psoriasis	0.000144	0.000537	CcSEcCtD
Estramustine—CYP3A4—Biological oxidations—CYP2S1—psoriasis	0.000141	0.00362	CbGpPWpGaD
Estramustine—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	0.000139	0.00357	CbGpPWpGaD
Estramustine—Insomnia—Methotrexate—psoriasis	0.000138	0.000517	CcSEcCtD
Estramustine—ESR1—AP-1 transcription factor network—CXCL8—psoriasis	0.000138	0.00353	CbGpPWpGaD
Estramustine—ESR1—Validated nuclear estrogen receptor alpha network—JUN—psoriasis	0.000138	0.00353	CbGpPWpGaD
Estramustine—Nausea—Triamcinolone—psoriasis	0.000138	0.000514	CcSEcCtD
Estramustine—Dyspnoea—Methotrexate—psoriasis	0.000136	0.000509	CcSEcCtD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—TNF—psoriasis	0.000134	0.00344	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—JUN—psoriasis	0.000134	0.00343	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	0.000134	0.00343	CbGpPWpGaD
Estramustine—Vomiting—Betamethasone—psoriasis	0.000134	0.000499	CcSEcCtD
Estramustine—Vomiting—Dexamethasone—psoriasis	0.000134	0.000499	CcSEcCtD
Estramustine—Decreased appetite—Methotrexate—psoriasis	0.000133	0.000497	CcSEcCtD
Estramustine—Rash—Betamethasone—psoriasis	0.000133	0.000495	CcSEcCtD
Estramustine—Rash—Dexamethasone—psoriasis	0.000133	0.000495	CcSEcCtD
Estramustine—Dermatitis—Betamethasone—psoriasis	0.000132	0.000495	CcSEcCtD
Estramustine—Dermatitis—Dexamethasone—psoriasis	0.000132	0.000495	CcSEcCtD
Estramustine—Headache—Betamethasone—psoriasis	0.000132	0.000492	CcSEcCtD
Estramustine—Headache—Dexamethasone—psoriasis	0.000132	0.000492	CcSEcCtD
Estramustine—ESR1—Regulation of Telomerase—JUN—psoriasis	0.000131	0.00336	CbGpPWpGaD
Estramustine—Pruritus—Prednisone—psoriasis	0.00013	0.000484	CcSEcCtD
Estramustine—ESR2—SIDS Susceptibility Pathways—NFKB1—psoriasis	0.000129	0.0033	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—JUN—psoriasis	0.000128	0.00328	CbGpPWpGaD
Estramustine—ESR1—Regulation of Telomerase—NFKB1—psoriasis	0.000126	0.00324	CbGpPWpGaD
Estramustine—Diarrhoea—Prednisone—psoriasis	0.000125	0.000468	CcSEcCtD
Estramustine—ESR1—LKB1 signaling events—TP53—psoriasis	0.000125	0.0032	CbGpPWpGaD
Estramustine—Nausea—Betamethasone—psoriasis	0.000125	0.000466	CcSEcCtD
Estramustine—Nausea—Dexamethasone—psoriasis	0.000125	0.000466	CcSEcCtD
Estramustine—CYP3A4—Tryptophan metabolism—CAT—psoriasis	0.000122	0.00312	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—IL10—psoriasis	0.000121	0.0031	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—IL4—psoriasis	0.000118	0.00302	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—VEGFA—psoriasis	0.000117	0.003	CbGpPWpGaD
Estramustine—ESR1—Leptin signaling pathway—NFKB1—psoriasis	0.000117	0.00299	CbGpPWpGaD
Estramustine—Vomiting—Prednisone—psoriasis	0.000116	0.000435	CcSEcCtD
Estramustine—Rash—Prednisone—psoriasis	0.000115	0.000431	CcSEcCtD
Estramustine—Dermatitis—Prednisone—psoriasis	0.000115	0.000431	CcSEcCtD
Estramustine—ABCB1—Allograft Rejection—HLA-B—psoriasis	0.000115	0.00295	CbGpPWpGaD
Estramustine—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	0.000115	0.00295	CbGpPWpGaD
Estramustine—Headache—Prednisone—psoriasis	0.000115	0.000428	CcSEcCtD
Estramustine—ESR2—Generic Transcription Pathway—VDR—psoriasis	0.000114	0.00293	CbGpPWpGaD
Estramustine—ESR1—Regulation of nuclear SMAD2/3 signaling—JUN—psoriasis	0.000114	0.00292	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	0.000114	0.00292	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	0.00011	0.00281	CbGpPWpGaD
Estramustine—Nausea—Prednisone—psoriasis	0.000109	0.000406	CcSEcCtD
Estramustine—Pruritus—Methotrexate—psoriasis	0.000108	0.000404	CcSEcCtD
Estramustine—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	0.000107	0.00275	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—HLA-A—psoriasis	0.000107	0.00274	CbGpPWpGaD
Estramustine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000105	0.00269	CbGpPWpGaD
Estramustine—ESR1—Leptin signaling pathway—STAT3—psoriasis	0.000105	0.00269	CbGpPWpGaD
Estramustine—Diarrhoea—Methotrexate—psoriasis	0.000105	0.000391	CcSEcCtD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	0.000103	0.00264	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—TNF—psoriasis	0.0001	0.00257	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	9.95e-05	0.00255	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	9.75e-05	0.0025	CbGpPWpGaD
Estramustine—Vomiting—Methotrexate—psoriasis	9.73e-05	0.000363	CcSEcCtD
Estramustine—ESR1—Generic Transcription Pathway—CARM1—psoriasis	9.66e-05	0.00248	CbGpPWpGaD
Estramustine—Rash—Methotrexate—psoriasis	9.65e-05	0.00036	CcSEcCtD
Estramustine—Dermatitis—Methotrexate—psoriasis	9.64e-05	0.00036	CcSEcCtD
Estramustine—Headache—Methotrexate—psoriasis	9.59e-05	0.000358	CcSEcCtD
Estramustine—ESR2—Gene Expression—CARM1—psoriasis	9.22e-05	0.00236	CbGpPWpGaD
Estramustine—Nausea—Methotrexate—psoriasis	9.09e-05	0.000339	CcSEcCtD
Estramustine—ESR1—ATF-2 transcription factor network—IL6—psoriasis	8.88e-05	0.00228	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	8.66e-05	0.00222	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	8.53e-05	0.00219	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—TYK2—psoriasis	8.52e-05	0.00218	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—TP53—psoriasis	8.46e-05	0.00217	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—IL6—psoriasis	8.09e-05	0.00207	CbGpPWpGaD
Estramustine—ESR2—Generic Transcription Pathway—PPARG—psoriasis	7.98e-05	0.00204	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—IL6—psoriasis	7.75e-05	0.00198	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	7.52e-05	0.00193	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—IFNG—psoriasis	7.12e-05	0.00183	CbGpPWpGaD
Estramustine—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	7.11e-05	0.00182	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—JUN—psoriasis	6.93e-05	0.00178	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—HCAR2—psoriasis	6.85e-05	0.00175	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—NFKB1—psoriasis	6.67e-05	0.00171	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—CXCL8—psoriasis	6.62e-05	0.0017	CbGpPWpGaD
Estramustine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	6.21e-05	0.00159	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—VEGFA—psoriasis	6.05e-05	0.00155	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—TAGAP—psoriasis	5.94e-05	0.00152	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—VDR—psoriasis	5.77e-05	0.00148	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	5.74e-05	0.00147	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	5.53e-05	0.00142	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—VDR—psoriasis	5.51e-05	0.00141	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	5.45e-05	0.0014	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—VEGFA—psoriasis	5.38e-05	0.00138	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	5.02e-05	0.00129	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—CARM1—psoriasis	4.65e-05	0.00119	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—TNF—psoriasis	4.61e-05	0.00118	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—NDUFA5—psoriasis	4.61e-05	0.00118	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	4.58e-05	0.00117	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—TP53—psoriasis	4.57e-05	0.00117	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	4.3e-05	0.0011	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	4.28e-05	0.0011	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—IL6—psoriasis	4.17e-05	0.00107	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	4.09e-05	0.00105	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—PPARG—psoriasis	4.02e-05	0.00103	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CYP2S1—psoriasis	3.92e-05	0.001	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—PPARG—psoriasis	3.84e-05	0.000984	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	3.79e-05	0.000971	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CCL20—psoriasis	3.56e-05	0.000911	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	3.04e-05	0.000779	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	2.92e-05	0.000749	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—NDUFA5—psoriasis	2.84e-05	0.000728	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—VDR—psoriasis	2.78e-05	0.000712	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	2.65e-05	0.00068	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CYP2S1—psoriasis	2.41e-05	0.000619	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	2.27e-05	0.000583	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	2.01e-05	0.000514	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—SOCS1—psoriasis	1.96e-05	0.000502	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—PPARG—psoriasis	1.94e-05	0.000496	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CARM1—psoriasis	1.91e-05	0.00049	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—LEP—psoriasis	1.45e-05	0.00037	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—APOE—psoriasis	1.45e-05	0.00037	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—NFKBIA—psoriasis	1.35e-05	0.000345	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CARM1—psoriasis	1.18e-05	0.000302	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CAT—psoriasis	1.18e-05	0.000302	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—TYK2—psoriasis	1.1e-05	0.000283	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CXCL8—psoriasis	9.6e-06	0.000246	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—APOE—psoriasis	9.15e-06	0.000234	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—JUN—psoriasis	8.93e-06	0.000229	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—NFKB1—psoriasis	8.6e-06	0.00022	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PPARG—psoriasis	7.97e-06	0.000204	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—VEGFA—psoriasis	7.8e-06	0.0002	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—STAT3—psoriasis	7.72e-06	0.000198	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CAT—psoriasis	7.25e-06	0.000186	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—TP53—psoriasis	5.89e-06	0.000151	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—APOE—psoriasis	5.63e-06	0.000144	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—IL6—psoriasis	5.4e-06	0.000138	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PPARG—psoriasis	4.91e-06	0.000126	CbGpPWpGaD
